RIPK3 and kidney disease Juan Guerrero-Mauvecin; Miguel Fontecha-Barriuso; Ana M. López-Diaz; Alberto Ortiz; Ana B. Sanz;

Adverse renal effects of check-point inhibitors (ICI) in cancer patients: Recommendations of the Onco-nephrology Working Group of the Spanish Society of Nephrology Fabiola Alonso; Ángel L.M. Martín de Francisco; Pilar Auñón; Clara García-Carro; Patricia García; Eduardo Gutiérrez; Manuel Mcía; Luis F. Quintana; Borja Quiroga; María José Soler; Isidro Torregrosa;

AKI development is an independent predictor of mortality in infective endocarditis Tatiana Niño Mojica; Alicia Cabrera Cárdenas; Laura Salanova; Ignacio Gómez Rojas; Paloma Ruíz López-Alvarado; Almudena Núñez Sánchez; Pablo Ruano; Borja Quiroga;